Authors


Marina Necdina

Latest:

The COVID-19 Pandemic and Its Positive Impact on RNA Drug Development

The COVID-19 pandemic helped to showcase RNA molecules and their therapeutic potential. There were also lessons learned in terms of drug delivery, manufacturing, logistics, and storage.


DuPont Nutrition & Biosciences 

Latest:

The Age of Big Q: A Full Organization Obsession with Customer Success

Quality is one of the most important components of products in pharmaceuticals. Traditionally, the onus was on the manufacturing function to deliver quality. But what if every single member of the organization was completely focused on customer needs? Big Q, or Quality culture, ensures that quality is up to everyone. DuPont expert will discuss more about how its excipient platform is taking customer cues to implement this total quality focus.


Richard J. Boeh

Latest:

Design of an Aseptic Process Simulation

The authors suggest a design strategy for an aseptic process simulation that focuses on the basic repeating unit of the process, establishing alert and action criteria for the unit itself, and using worst-case simulations to establish routine operational parameters for the manufacturing process.


Natalie Balanvosky

Latest:

Demystifying Complex Clinical Trial Kit Preparation

Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.


Scott Barnhart

Latest:

Dissolvable Films: Dissolvable Films for Flexible Product Format in Drug Delivery

For pediatric and geriatric patients, fast-dissolving drug-delivery systems provide an easier way to take medications and vitamins. Oral thin films have evolved to provide systemic delivery of active pharmaceutical ingredients for over-the-counter and soon, prescription drugs. The authors review the practical benefits of dissolvable films, their manufacture, and their market potential.


Chad Andersen

Latest:

Exploring Best Practice Tech Transfer Methods for CGTs

Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.


Thomas Cullen

Latest:

A Harmonized Approach to Performing a Risk-Based Audit Trail Review

The IQ Working Group has defined a pragmatic risk-based approach to audit trail review, where it is only required for high impact GxP data.


Saikat Banerjee

Latest:

Development of a Validated Method of Testing for NDMA in Ranitidine

This article describes a validated method, using liquid chromatography/mass spectrometry, for detecting the carcinogenic impurity NDMA (N-nitrosodimethylamine) in ranitidine that meets and exceeds FDA’s limit of detection and limit of quantitation requirements.


Lori Stansberry

Latest:

Is Collaboration the Key to Accelerating Biotherapeutic Development?

Vendors are finding ways to address the increasingly complex analytical challenges in the biopharmaceutical industry to further biotherapeutic development.


S. Rangappa

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Keith Dixon

Latest:

Manufacturing Considerations for Sourcing GMP Fermentation Services

The authors describe the critical aspects of an ideal fermentation services provider.


Scott Reynolds

Latest:

Characterization of the Performance of Bin Blenders-Part 3 of 3: Cohesive Powders

In this final part of a series of three articles, the results from experiments involving cohesive materials are discussed in terms of mixing performance, agglomerate comminution, and lubrication of powder mixtures.


Naveenganesh Muralidharan

Latest:

Understanding the Variability in Bioburden Test Results in Biomanufacturing

This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.


Krunal Jasani

Latest:

Using Quality by Design to Develop Fixed-Dose Combination Tablets

In the present investigation, the fixed-dose combination (FDC) tablet of Atorvastatin calcium and Ezetimibe was prepared by a quality-by-design approach using two-level factorial design.



Colbert Packaging

Latest:

Safe, Smart, and Sustainable Packaging for the Healthcare Industry

Colbert Packaging specializes in safe, smart, and sustainable paperboard packaging for the pharmaceutical and healthcare industries, differentiating itself through industry-focused investments and a commitment to environmental responsibility.


Tao Peng

Latest:

Polysorbates: Part(icle) of the Problem?

A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.


Gerald Tyers

Latest:

Reliance-Based Waivers Become the Predominant Trend in In-Country Testing of Pharmaceutical Products

This study reviews changes in in-country testing (registration testing, import testing) requirements and analyzes current trends. In the context of international harmonization of good practices and standards as well as the improved information exchange between national regulatory authorities, in-country testing is considered outdated and redundant in many cases.


David Skanchy

Latest:

Master File Submission of Structures

The SD File format offers benefits for KASA and cheminformatics to support regulatory submissions.


Cytiva

Latest:

A throughput benchmarking study of Supor™ Prime filters (July 2024)

See how Supor Prime filters performed against two comparable products in filtering fluids with antibody concentrations of 70 g/L to 220 g/L. And be sure to request a sample!


Christopher Ziegenfuss

Latest:

ICH Q6B for Analytics

ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.


Qualicaps

Latest:

2020 Bio/Pharma Virtual Congress

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021


Paul Suszczynski

Latest:

Determining Low PPB Levels of Nitrite in Polymeric Excipients

In this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.



Ralph M. Dioguardi

Latest:

Use Of RFID Asset Management Systems For Monitoring Analytical Instrumentation

Utilizing integrated active radio frequency identification (RFID) and real-time asset management systems can yield commercial and compliance benefits.


John Y. Lee

Latest:

Change management: common failures and a checklist for improvement

Though the pharma industry has improved its change management processes, there are still opportunities for improvement.



Andrew Walker

Latest:

Integrated Approach Facilitates Inhalation Drug Development

The choice of delivery platform for inhaled drug products is contingent on API-related factors, as well as the development stage of the product.


Jared Finger

Latest:

Viral Vector API Characterization of Product-Related Impurities

FDA’s final CMC guidance sets expectations for manufacturing and quality for human gene therapy INDs. This article reviews existing analytical applications, focusing on viral vector characterization of impurities.